UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037591
Receipt number R000042856
Scientific Title A single-center retrospective study regarding the hemostasis rate after emergency lower gastrointestinal endoscopy following contrast-enhanced CT in patients with acute hemorrhage of the lower digestive tract
Date of disclosure of the study information 2019/08/05
Last modified on 2023/02/05 11:57:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-center retrospective study regarding the hemostasis rate after emergency lower gastrointestinal endoscopy following contrast-enhanced CT in patients with acute hemorrhage of the lower digestive tract

Acronym

A single-center retrospective study regarding the hemostasis rate after emergency lower gastrointestinal endoscopy following contrast-enhanced CT in patients with acute hemorrhage of the lower digestive tract

Scientific Title

A single-center retrospective study regarding the hemostasis rate after emergency lower gastrointestinal endoscopy following contrast-enhanced CT in patients with acute hemorrhage of the lower digestive tract

Scientific Title:Acronym

A single-center retrospective study regarding the hemostasis rate after emergency lower gastrointestinal endoscopy following contrast-enhanced CT in patients with acute hemorrhage of the lower digestive tract

Region

Japan


Condition

Condition

colonic diverticular bleeding

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine whether there is a significant decrease in the hemostasis rate after emergency lower gastrointestinal endoscopy following contrast-enhanced CT in comparison with the elective contrast-enhanced CT group in patients with acute hemorrhage of the lower digestive tract.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rate of patients in whom the source of hemorrhage was identified using contrast-enhanced CT of the lower digestive tract, rate of patients in whom the source of hemorrhage was identified using emergency lower gastrointestinal endoscopy, and rebleeding rate within 7 days after the initial onset.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

37 years-old <=

Age-upper limit

96 years-old >=

Gender

Male and Female

Key inclusion criteria

patients with hemorrhage of the lower digestive tract requiring admission, those who underwent contrast-enhanced CT at the Emergency Outpatient Unit or during admission, followed by detailed examination for gastrointestinal hemorrhage, and those aged more than 20 years on admission.

Key exclusion criteria

patients with hematemesis, black vomit, or tarry stool, those who underwent upper gastrointestinal endoscopy and were diagnosed with hemorrhage of the upper digestive tract, and those who underwent IVR or abdominal surgery during admission.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Toshiro
Middle name
Last name Kamoshida

Organization

Hitachi General Hospital

Division name

Department of Gastroenterology

Zip code

317-0077

Address

2-1-1, Jonan-cho, Hitachi City, Ibaragi Prefecture

TEL

0294-23-1111

Email

toshiro.kamoshida.fu@hitachi.com


Public contact

Name of contact person

1st name Toshiro
Middle name
Last name Kamoshida

Organization

Hitachi General Hospital

Division name

Department of Gastroenterology

Zip code

317-0077

Address

2-1-1, Jonan-cho, Hitachi City, Ibaragi Prefecture

TEL

0294-23-1111

Homepage URL


Email

toshiro.kamoshida.fu@hitachi.com


Sponsor or person

Institute

Hitachi General Hospital

Institute

Department

Personal name



Funding Source

Organization

Hitachi General Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hitachi General Hospital

Address

2-1-1, Jonan-cho, Hitachi City, Ibaragi Prefecture

Tel

0294-23-1111

Email

toshiro.kamoshida.fu@hitachi.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 05 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040177/

Publication of results

Partially published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040177/

Number of participants that the trial has enrolled

317

Results

SRH were identified in 35.0% (35/100) of the urgent CT cases and 7.3% (6/82) of the elective CT cases (P < 0.01). Among all patients with extravasation-positive images on CT, SRH was identified in 31 out of 47 patients (66.0%) in the urgent CT group and 4 out of 20 patients (20.0%) in the elective CT group (P < 0.01). Furthermore, rates of rebleeding within 30 d were significantly improved in the urgent CT and extravasation-positive cases (P < 0.05).

Results date posted

2023 Year 02 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Colonoscopy within 24 h of hospital admission for colonic diverticular bleeding (CDB) is recommended. However, little is known about rates of rebleeding within 30 d. We posited that a group of patients who underwent contrast-enhanced computed tomography (CT) within 4 h of the last hematochezia and colonoscopy within 24 h would experience fewer incidences of rebleeding.

Participant flow

Data from 182 patients with CDB who underwent contrast-enhanced CT and colonoscopy between January 2011 and December 2018 at the study site were retrospectively reviewed. Patients were divided into groups based on the timing of the CT imaging, within or at 4 h were defined as urgent CTs (n = 100) and those performed after 4 h were defined as elective CTs (n = 82). Main outcomes included rebleeding within 30 d and the identification of stigmata of recent hemorrhage (SRH) (i.e., active bleeding, non-bleeding visible vessels, or adherent clots).

Adverse events

N/A

Outcome measures

The rate of extravasation-positive images, SRH, rebleeding within 30 day

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 04 Month 10 Day

Date of IRB

2019 Year 06 Month 03 Day

Anticipated trial start date

2019 Year 06 Month 03 Day

Last follow-up date

2020 Year 01 Month 31 Day

Date of closure to data entry

2020 Year 02 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

(1) Approval by the Ethics Review Board
The principal investigator will submit the protocol of this study to the Ethics Review Board of this institution for inspection, and obtain approval on the study execution from the director of this institution.
(2) Study type/design
A single-center, retrospective, comparative study.
(3) Study period
One year.
(4) Storage of samples from human bodies and information to be used for research
The information obtained in this study will be centrally stored on a security-assured personal computer.
The data will be anonymized, and used for this study alone. As a rule, the principal investigator of this institution must store the data on a password-locked personal computer and paper materials in a key-locked locker in this institution.
As a rule, the data input to a personal computer should be stored for 5 years or 3 years after the publication of an article (the longer period should be chosen).


Management information

Registered date

2019 Year 08 Month 04 Day

Last modified on

2023 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042856


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name